Insider Transactions in Q1 2023 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.8%
|
$180,000
$18.05 P/Share
|
|
Mar 07
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-1.05%
|
$250,000
$20.01 P/Share
|
|
Mar 01
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-7.04%
|
$450,000
$18.61 P/Share
|
|
Feb 17
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
9,377
-3.45%
|
$187,540
$20.03 P/Share
|
|
Feb 16
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
930
-0.34%
|
$17,670
$19.57 P/Share
|
|
Feb 16
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
674
-0.05%
|
$12,806
$19.57 P/Share
|
|
Feb 16
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,022
-0.25%
|
$57,418
$19.57 P/Share
|
|
Feb 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.66%
|
-
|
|
Feb 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
Feb 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.35%
|
-
|
|
Feb 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.8%
|
$200,000
$20.07 P/Share
|
|
Feb 01
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-3.3%
|
$525,000
$21.45 P/Share
|
|
Jan 23
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-1.05%
|
$275,000
$22.0 P/Share
|
|
Jan 20
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-3.59%
|
$220,000
$22.75 P/Share
|
|
Jan 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.4%
|
$220,000
$22.98 P/Share
|
|
Jan 03
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-3.13%
|
$500,000
$20.84 P/Share
|